Human Cloning Isn’t Monkey Business
By Osagie K. Obasogie,
Genetic Crossroads
| 11. 29. 2007
Rarely have science, politics, and international diplomacy converged as intensely as they have over the past few days.
Researchers at the Oregon National Primate Research Center have accomplished what some scientists equate with breaking the sound barrier: creating cloned embryos from an adult monkey and isolating its stem cells. Since monkeys are humans' closest relatives and embryonic stem cells might treat devastating injuries and diseases, this research has invigorated prospects for developing patient-specific embryonic stem cells for humans by copying the Oregon researchers' new approach. After all, monkey see, monkey do.
Yet another level of intrigue comes from the fact that cloning an embryo to obtain stem cells involves the same underlying process as cloning an embryo to create a living, breathing clone: taking the nucleus from a body cell, sticking it into an egg, and triggering its early development. Research cloning involves stopping this development after a few days to cull the early embryos' stem cells; reproductive cloning entails placing the developing embryo into a surrogate until the clone is born.
Scientists have not yet created a living cloned...
Related Articles
By Jonathan Grinstein, Neo.Life | 05.19.2022
The real-life creation of human-animal hybrids, which is on the verge of going from hypothesis to reality, has been the subject of ongoing debate since the dawn of genetic engineering. But recent advances have made these creatures of dreams (or...
By Antonio Regalado, MIT Technology Review | 05.04.2022
The pig heart transplanted into an American patient earlier this year in a landmark operation carried a porcine virus that may have derailed the experiment and contributed to his death two months later, say transplant specialists.
David Bennett Sr. was...
By Melissa Waddell, Living Non-GMO | 03.03.2022
The biotech industry loves to talk about precision.
For example, advocates for genetic engineering and genetic modification have adopted the term “precision agriculture” to rebrand unpopular technologies that produce GMOs. Divorced from its meaning, precision agriculture sounds very...
By GMWatch, GMWatch | 04.19.2022
Bayer AG is a chemical and pharmaceutical giant founded in Barmen, Germany in 1863 by Friedrich Bayer and his partner, Johann Friedrich Weskott. Today it has its headquarters in Leverkusen, North Rhine-Westphalia, Germany.
The merger between Bayer and Monsanto in...